Theralase Technologies Inc. V.TLT

Nothing

[Johnandrose22]

It is a bit disappointing when the company’s management, at it’s own AGM, has virtually nothing to say to it’s investors.

[Oilminerdeluxe]

Yes indeed. But sort of expected. It's the newsletter we have to wait for right now. That one, or the next after that, should have quite more information in it. 

[Oden6570]

After last year's AGM I did not bother to watch this one. I am assuming the CEO again put on a very lackluster show , similar to our sp.

[fredgoodwinson]

Dead on Oden. Yes it seems all we will be told now is via the Quarterly and then not much.Watched ‘live’ as a guest and struggled to keep up with what little there was while simultaneously attempting to contextualise. Haven`t been able to refer back so the following is from suspect memory.   NMIBC - just rattled through the figures in the table. Can only hope the high ‘no response’ is

[StevenBirch]

Yes and looking back now it seems like we should not have expected much with the quarterly report due within weeks. And the delivery proved it, get through the 'business' and tell us basically what we already knew.

[skys1]

"lackluster show"? It was far worse than I was ready for. Each year I watch a dozen or so  AGMs. Each are always lead by an upbeat CEO putting the companies "best foot forward" to tout the companies achievements and future prospects. Often accompanied by others like the CFO or doctors to second that opinion. This was nothing like that, and in fact was a debacle IMO. What a

[Sosak1]

I can see that TLT management has finally learnd from past mistakes they made. Because at this stage of the game it is better to be quiet and not telling what is going on. Big Pharma is watching and if they don't know better for us. When we will get a Brakeakthrough status then it will be different game.

[menoalittle]

>> Because at this stage of the game it is better to be quiet >> and not telling what is going on. strangely enough, I find myself in agreement (and perhaps somewhat bewitched) with that... as in, yeah... anyone that isn't savvy enough to read between the lines... f'em.  They can belly up to the bar and pay whatever the going price is later, when it's so

[Johnandrose22]

I would respectfully disagree, Menoalittle....When the company, just a few days before the AGM, publically describes itself as “Destroying Cancer...” and “Healing The World...” they’re not hiding what they have. They are letting everyone know they are defining themselves by what they believe is in their possession. To then present to those who have supported them via investment with as much

[stocksnbonds458]

Agreed skys1, other than Dr Sherri the management and supporting cast are a bit of a gong show (refer to Phase 2 F-ups for clarification per said non-technical terminology). In spite of the assembled "Dream Team" her breakthrough will win out in the end. IMO we have an almost 2 year wait for "Breakthrough" FDA approval once we have our 20-25 phase 2 patients enrolled with which

[newdaydawning]

Excellent post. The timelines you lay out are realistic and very credible. And your advice to hang tight is very prescient. Based on the science and the clinic, this will be a very different company - in a good way - a mere two years out.

[tamarindo1]

As someone on here once said, ( I bought too early).  Oh well!  That's what Grandkids are for.  :-)  

[Pandora]

But there are times when you think it would be nicer to give it to them rather than leave it for them.

[Rumpl3StiltSkin]

S&B I think that is about right. I do think we're close enough to 20 that the clock could have already started. I know everyone says 25 but I think a solid 20 and with 6 months + 9 months data of additional patients, FDA will take that into account. CR%s should start averaging in the high 50s IMO for the optimized patients. So with ~40-50 patients total we may even break into CR %s into

[Rumpl3StiltSkin]

Maybe they should have done the AGM in the fall? Didn't they used to? Anyway, I don't think CR%s have changed in these latest numbers, right? So we're just waiting for the optimized cohort and additional optimized to be treated so we can get their CR data in the pipeline. Then, in a year the 'real CR% will come into light. And, perhaps soon we'll hear from Dr. Sausage! ;-)